Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Pharma heading for collision course over cancer drug costs

March 16, 2006 Sales and Marketing

Fears that the pharmaceutical industry could be on a collision course with Europe's healthcare payers over new high priced medicines …
News

A place in pharma’s history of innovation

March 15, 2006 Sales and Marketing prix galien

Registration has begun for entrants to the 2006 UK Prix Galien, which takes place at the Houses of Parliament this …
Feature

Schering to fight takeover bid from Merck KGaA

March 14, 2006 Sales and Marketing

A hostile takeover bid has been launched by Merck KGaA for rival German pharmaceutical company Schering.Both companies are enjoying strong …
News

We’re part of the solution, pharma tells Europe

March 13, 2006 Sales and Marketing

Europe’s pharmaceutical industry body EFPIA has launched a new promotional campaign for the sector, which it hopes will raise awareness …
News

New Novartis blindness treatment filed in Europe

March 2, 2006 Sales and Marketing AMD, Lucentis, Novartis

Lucentis, a new treatment for neovascular age-related macular degeneration or ‘wet AMD’ has been submitted by Novartis to the European …
News

GSK launches Europe’s first rotavirus vaccine

March 1, 2006 Sales and Marketing

GlaxoSmithKline has launched Rotarix in Europe, the first ever marketed vaccine against rotavirus gastroenteritis, a common but potentially lethal condition …
News

Bioenvision’s leukaemia treatment gains positive opinion

March 1, 2006 Sales and Marketing

Bioenvision has received a positive opinion from the European Medicines Agency for Evoltra (clofarabine), the first drug specifically developed for …
News

Erbitux closer to head and neck cancer approval

March 1, 2006 Sales and Marketing

Merck KGaA's targeted cancer treatment Erbitux has moved a step closer to receiving EU approval to extend its licence to …
News

Novartis files new Hepatitis B treatment in Europe

February 28, 2006 Sales and Marketing

Novartis has filed its new hepatitis B treatment telbivudine in the European Union, and says it represents a potential new …
News

ABPI chief calls for ‘new rules of engagement’

February 23, 2006 Sales and Marketing

UK pharmaceutical industry leader Richard Barker has called for a fundamental rethink in the way the industry and the NHS …
News

Gene silencing technology to be used in war against bird flu

February 23, 2006 Sales and Marketing

Cutting edge technology will be used develop new drugs to treat dangerous strains of influenza, including the threat of a …
News

Sanofi’s wonder drug in limbo after regulator’s rejection

February 23, 2006 Sales and Marketing

The future of Sanofi-Aventis' Acomplia is in serious doubt after regulators demanded more data for its use in weight loss, …
News

Pegasys recommended as front line hepatitis B treatment

February 23, 2006 Sales and Marketing

Roche's Pegasys is set to be used more widely in England and Wales to treat hepatitis B following the release …
News

Merck files novel diabetes drug Januvia

February 16, 2006 Sales and Marketing

Merck has filed an innovative new diabetes treatment with the US regulator, and hopes the drug could be one of …
News

Safety scare spells the end for Exanta

February 15, 2006 Sales and Marketing

AstraZeneca is to abandon its novel anti-blood clotting drug Exanta after concerns emerged about its long-term safety.Just two years ago, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025